Patents by Inventor Sven-Ove Ogren

Sven-Ove Ogren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds of diphenylcyclopentylamine type and methods for their preparation
    Patent number: 4141993
    Abstract: Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof, wherein X and Y are the same or different and each represents a hydrogen atom, a chloro or a methoxy group, n is an integer 0 or 1 and R.sup.1 and R.sup.2 are the same or different and each representing a hydrogen atom or a methyl group; processes for their preparation; pharmaceutical preparations containing at least one of these compounds and the use thereof in the treatment of depressive states.
    Type: Grant
    Filed: May 19, 1977
    Date of Patent: February 27, 1979
    Assignee: Astra Lakemedel Aktiebolaget
    Inventors: Bernt S. E. Carnmalm, Ulf H. A. Lindberg, Tomas De Paulis, Svante B. Ross, Nils-Erik Stjernstrom, Carl B. J. Ulff, Sven-Ove Ogren
  • Trifluoromethyl substituted compounds having antidepressive activity
    Patent number: 4098901
    Abstract: A compound of the formula ##STR1## and pharmaceutically acceptable acid addition salts thereof, in which formula the group R.sup.o is trifluoromethyl.Pharmaceutical compositions containing these compounds are useful for treatment of depressive disorders.
    Type: Grant
    Filed: August 30, 1976
    Date of Patent: July 4, 1978
    Assignee: Astra Lakemedel Aktiebolag
    Inventors: Ulf Henrik Anders Lindberg, Svante Bertil Ross, Seth Olov Thorberg, Sven Ove Ogren
  • Compounds of spiro-amine type and methods for their use
    Patent number: 4053632
    Abstract: Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof; processes for their preparation; intermediates useful for their preparation; pharmaceutical preparations containing at least one of these compounds; and the use thereof as a tranquilizing or neuroleptic agent.
    Type: Grant
    Filed: December 27, 1974
    Date of Patent: October 11, 1977
    Assignee: Astra Lakemedel Aktiebolag
    Inventors: Bernt Sigfrid Emanuel Carnmalm, Tomas De Paulis, Svante Bertil Ross, Sten Ingvar Ramsby, Nils-Erik Stjernstrom, Sven-Ove Ogren
  • Compounds of diphenylcyclopentylamine type and methods for their uses
    Patent number: 4053637
    Abstract: Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof, wherein X and Y are the same or different and each representing a hydrogen atom, a chloro or a methoxy group, n is an integer 0 or 1 and R.sup.1 and R.sup.2 are the same or different and each representing a hydrogen atom or a methyl group; processes for their preparation; pharmaceutical preparations containing at least one of these compounds and the use thereof in the treatment of depressive states.
    Type: Grant
    Filed: May 20, 1975
    Date of Patent: October 11, 1977
    Assignee: Astra Lakemedal Aktiebolag
    Inventors: Bernt Sigfrid Emanuel Carnmalm, Ulf Henrik Anders Lindberg, Tomas DE Paulis, Svante Bertil Ross, Nils-Erik Stjernstrom, Carl Bengt Johan Ulff, Sven-Ove Ogren
  • Pharmaceutical compositions containing an amphetamine derivative for the alleviation of anxiety or treatment of depression
    Patent number: 4000280
    Abstract: Compounds having the general formula ##STR1## or pharmaceutically acceptable salts thereof, in which formula R.sup.1 and R.sup.2 are the same or different and each represents a hydrogen atom, a lower alkyl group or a halogen atom, R.sup.3 represents a lower alkyl group or a benzyl group, R.sup.4 represents a hydrogen atom, a lower alkyl group, a benzyl group or a CH.sub.2 CH.sub.2 CH.sub.2 -bridge connected to the phenyl ring in ortho-position relative to the N-substituent, R.sup.5 represents a hydrogen atom or a methyl group and R.sup.6 represents a lower alkyl group, provided that R.sup.1 and/or R.sup.2 represents a lower alkyl group or a halogen atom where R.sup.3 represents a methyl group, R.sup.4 represents a methyl group and R.sup.5 represents a hydrogen atom; methods for the preparation thereof; intermediates useful for their preparation; pharmaceutical preparations containing at least one of these compounds; and the use thereof in the treatment of depressive states and alleviating anxiety.
    Type: Grant
    Filed: June 30, 1975
    Date of Patent: December 28, 1976
    Assignee: Astra Lakemedel Aktiebolag
    Inventors: Gosta Lennart Florvall, Svante Bertil Ross, Sven-Ove Ogren
  • Amphetamine derivatives
    Patent number: 3996381
    Abstract: Compounds having the general formula ##STR1## or pharmaceutically acceptable salts thereof, in which formula R.sup.1 and R.sup.2 are the same or different and each represents a hydrogen atom, a lower alkyl group or a halogen atom, R.sup.3 represents a lower alkyl group or a benzyl group, R.sup.4 represents a hydrogen atom, a lower alkyl group, a benzyl group or a CH.sub.2 CH.sub.2 CH.sub.2 --bridge connected to the phenyl ring in ortho-position relative to the N-substituent, R.sup.5 represents a hydrogen atom or a methyl group and R.sup.6 represents a lower alkyl group, provided that R.sup.1 and/or R.sup.2 represents a lower alkyl group or a halogen atom when R.sup.3 represents a methyl group, R.sup.4 represents a methyl group and R.sup.5 represents a hydrogen atom; methods for the preparation thereof; intermediates useful for their preparation; pharmaceutical preparations containing at least one of these compounds; and the use thereof in the treatment of depressive states and alleviating anxiety.
    Type: Grant
    Filed: August 14, 1974
    Date of Patent: December 7, 1976
    Assignee: Astra Lakemedel Aktiebolag
    Inventors: Gosta Lennart Florvall, Svante Bertil Ross, Sven-Ove Ogren